Liraglutide Hospital Discharge Trial

NCT01919489 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

273

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide + OADs
DRUG: Glargine + OADs

Sponsor

Emory University

Collaborators

[object Object]